BIIB
Biogen Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website biogen.com
- Employees(FY) 8725
- ISIN US09062X1037
Performance
1W
1M
3M
6M
YTD
1Y
Profile
Investment Analysis Report: Biogen Inc. (BIIB)
Overview
Biogen Inc. (BIIB) operates in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has a market capitalization of $32.46 billion. In this report, we will conduct a comprehensive analysis of BIIB's financial health, valuation, earnings and revenue g...
Technical Analysis of BIIB 2024-07-18
Overview
Analyzing the recent technical indicators for Biogen Inc. (BIIB) provides a comprehensive view of its potential price movements in the upcoming days. The data from the last five trading sessions reveals a mix of trends, momentum shifts, volatility patterns, and volume changes that can help us forecast the stock's trajectory.
Trend Indi...
Recent News & Updates
- 2024-07-27 01:14
- 2024-07-26 11:26
- 2024-07-26 11:13
Biogen Stock Tumbles After European Regulators Unexpectedly Reject Alzheimer's Drug(Investor's Business Daily)
- 2024-07-26 10:48
- 2024-07-26 10:21
- 2024-07-26 10:09
Baird Adjusts Price Target on Biogen to $294 From $316(MT Newswires)
- 2024-07-26 10:01
- 2024-07-26 09:48
European committee says Alzheimer's treatment Leqembi shouldn't get marketing approval(Associated Press Finance)
- 2024-07-26 07:20
- 2024-07-25 19:20
- 2024-07-25 10:02
- 2024-07-25 04:52
Sage and Biogen’s SAGE-324 shows no benefit in essential tremor trial(Clinical Trials Arena)
- 2024-07-24 10:58
- 2024-07-24 10:34
Sage Therapeutics Stock Slides as Pipeline Thins(Barrons.com)
- 2024-07-24 09:37
Is Biogen (BIIB) an Underappreciated Stock?(Insider Monkey)
- 2024-07-24 08:10
Biogen, Sage tremor drug fails key trial(BioPharma Dive)
- 2024-07-24 06:30
- 2024-07-23 21:01
- 2024-07-23 18:30
- 2024-07-23 03:52
Nanotechnology in medicine: Who are the leading public companies?(Medical Device Network)
- 2024-07-22 11:52
Ionis Pharmaceuticals Surges Into Buy Zone As It, Possibly, Proves Biogen Wrong(Investor's Business Daily)
- 2024-07-22 08:14
Ionis plots next steps for Angelman drug Biogen passed on(BioPharma Dive)
- 2024-07-22 01:12
Sage Therapeutics/Biogen’s episodic therapy zuranolone could change MDD treatment(Clinical Trials Arena)
- 2024-07-19 09:56
- 2024-07-18 12:55
Is Eli Lilly Stock A Sell On A Rare Stumble In Obesity Treatment?(Investor's Business Daily)
- 2024-07-17 09:50
- 2024-07-17 04:02
- 2024-07-17 00:45
- 2024-07-16 11:55
Biogen Has Up To $10 Billion For Acquisitions; Why These Three Names Make Sense(Investor's Business Daily)
- 2024-07-16 11:27